U
Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
E
Sell
7/24/2024Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 7/24/2024 due to a noticeable decline in the volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 7/24/2024 due to a noticeable decline in the volatility index.
D
Sell
6/20/2024Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 6/20/2024 due to an increase in the volatility index and total return index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 6/20/2024 due to an increase in the volatility index and total return index.
E
Sell
6/5/2024Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 6/5/2024 due to a decline in the volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 6/5/2024 due to a decline in the volatility index.
D
Sell
4/29/2024Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
E
Sell
4/12/2024Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
D
Sell
3/13/2024Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 3/13/2024 due to an increase in the volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 3/13/2024 due to an increase in the volatility index.
E
Sell
2/27/2024Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
D
Sell
2/12/2024Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 2/12/2024 due to a noticeable increase in the total return index and volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 2/12/2024 due to a noticeable increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D on 03/14/2023.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D from E+ on 02/09/2023.
Black Bird Biotech, Inc. (BBBT) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D on 02/08/2023.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D on 02/08/2023.
D
Sell
12/27/2022Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 12/27/2022 due to an increase in the volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 12/27/2022 due to an increase in the volatility index.
D
Sell
12/12/2022Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 12/12/2022 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.1 to 0.08, and debt to equity increased from -1.3 to -1.13.
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 12/12/2022 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.1 to 0.08, and debt to equity increased from -1.3 to -1.13.
D
Sell
11/8/2022Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 11/8/2022 due to a substantial increase in the valuation index and volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 11/8/2022 due to a substantial increase in the valuation index and volatility index.
D
Sell
10/21/2022Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 10/21/2022 due to a decline in the total return index and volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 10/21/2022 due to a decline in the total return index and volatility index.
D
Sell
10/3/2022Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 10/3/2022 due to an increase in the total return index and volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 10/3/2022 due to an increase in the total return index and volatility index.
D
Sell
9/15/2022Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 9/15/2022 due to a decline in the volatility index.
Black Bird Biotech, Inc. (BBBT) was downgraded to D- from D on 9/15/2022 due to a decline in the volatility index.
D
Sell
8/29/2022Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 8/29/2022 due to an increase in the valuation index, growth index and total return index. Total revenue increased 123.91% from $13.8 to $30.9, earnings per share increased from -$0.0022 to -$0.0017, and EBIT increased 4.45% from -$503 to -$480.6.
Black Bird Biotech, Inc. (BBBT) was upgraded to D from D- on 8/29/2022 due to an increase in the valuation index, growth index and total return index. Total revenue increased 123.91% from $13.8 to $30.9, earnings per share increased from -$0.0022 to -$0.0017, and EBIT increased 4.45% from -$503 to -$480.6.
D
Sell
5/5/2022Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 05/05/2022.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
D
Sell
11/23/2021Upgraded
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and volatility index.
Black Bird Biotech, Inc. (BBBT) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and volatility index.
E
Sell
11/8/2021Downgrade
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 11/8/2021 due to a significant decline in the solvency index and volatility index. The quick ratio declined from 0.28 to 0.19.
Black Bird Biotech, Inc. (BBBT) was downgraded to E+ from D- on 11/8/2021 due to a significant decline in the solvency index and volatility index. The quick ratio declined from 0.28 to 0.19.
D
Sell
4/16/2021Upgraded
Digital Development Partners, Inc. (DGDM) was upgraded to D- from E+ on 4/16/2021 due to a noticeable increase in the solvency index, growth index and valuation index. Debt to equity declined from 3.62 to 1.82.
Digital Development Partners, Inc. (DGDM) was upgraded to D- from E+ on 4/16/2021 due to a noticeable increase in the solvency index, growth index and valuation index. Debt to equity declined from 3.62 to 1.82.
E
Sell
12/17/2020Downgrade
Digital Development Partners, Inc. (DGDM) was downgraded to E+ from D- on 12/17/2020 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0002 to -$0.0015, EBIT declined 626.76% from -$29.9 to -$217.3, and operating cash flow declined 264.58% from -$51.1 to -$186.3.
Digital Development Partners, Inc. (DGDM) was downgraded to E+ from D- on 12/17/2020 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0002 to -$0.0015, EBIT declined 626.76% from -$29.9 to -$217.3, and operating cash flow declined 264.58% from -$51.1 to -$186.3.
D
Sell
10/1/2020Upgraded
Digital Development Partners, Inc. (DGDM) was upgraded to D- from E on 10/1/2020 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 408.47% from $5.9 to $30, earnings per share increased from -$0.0005 to -$0.0002, and EBIT increased 56.35% from -$68.5 to -$29.9.
Digital Development Partners, Inc. (DGDM) was upgraded to D- from E on 10/1/2020 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 408.47% from $5.9 to $30, earnings per share increased from -$0.0005 to -$0.0002, and EBIT increased 56.35% from -$68.5 to -$29.9.
E
Sell
7/1/2020Upgraded
Black Bird Potentials Inc. (DGDM) was upgraded to E from E- on 7/1/2020 due to an increase in the valuation index.
Black Bird Potentials Inc. (DGDM) was upgraded to E from E- on 7/1/2020 due to an increase in the valuation index.
E
Sell
3/30/2020None
Black Bird Biotech, Inc. (BBBT) was downgraded to E- from U on 03/30/2020.
Black Bird Biotech, Inc. (BBBT) was downgraded to E- from U on 03/30/2020.
OTC PK
04/03/2025 2:09PM Eastern
Quotes delayed
